After launch limitations, Johnson & Johnson exec touts manufacturing progress on CAR-T drug Carvykti
As Johnson & Johnson and Legend Biotech have sought to grow the reach of their multiple myeloma CAR-T drug Carvykti since winning FDA approval last year, they've...